# Retraction: Gravity-perfused airway-on-a-chip optimized for quantitative BSL-3 studies of SARS-CoV-2 infection: barrier permeability, cytokine production, immunohistochemistry, and viral load assays

**Authors:** Shannon L. Faley, Niloufar A. Boghdeh, David K. Schaffer, Eric C. Spivey, Farhang Alem, Aarthi Narayanan, John P. Wikswo, Jacquelyn A. Brown

PMC · DOI: 10.1039/d4lc90106a · Lab on a Chip · 2025-10-13

## TL;DR

This retraction notice addresses a paper on a microfluidic device for studying SARS-CoV-2 infection under high biosafety conditions.

## Contribution

The paper originally introduced a gravity-perfused airway-on-a-chip system for BSL-3 SARS-CoV-2 studies.

## Key findings

- The device enabled quantitative analysis of barrier permeability and cytokine production.
- It supported immunohistochemistry and viral load assays in a controlled environment.
- The system was optimized for high biosafety level experiments.

## Abstract

Retraction of ‘Gravity-perfused airway-on-a-chip optimized for quantitative BSL-3 studies of SARS-CoV-2 infection: barrier permeability, cytokine production, immunohistochemistry, and viral load assays’ by Shannon L. Faley et al., Lab Chip, 2024, 24, 1794–1807, https://doi.org/10.1039/D3LC00894K.

## Full-text entities

- **Diseases:** SARS-CoV-2 infection (MESH:D000086382)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12517326/full.md

---
Source: https://tomesphere.com/paper/PMC12517326